Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dermal Periostin: A New Player in Itch of Prurigo Nodularis.

Literature DB >> 33236123

Dermal Periostin: A New Player in Itch of Prurigo Nodularis.

Takashi Hashimoto¹, Leigh A Nattkemper, Hei Sung Kim, Christina D Kursewicz, Emilie Fowler, Serena M Shah, Sonali Nanda, Rachel A Fayne, Paolo Romanelli, Gil Yosipovitch.

Abstract

Entities: Chemical

Mesh：

Year: 2021 PMID： 33236123 PMCID： PMC9309858 DOI： 10.2340/00015555-3702

Source DB: PubMed Journal: Acta Derm Venereol ISSN： 0001-5555 Impact factor: 3.875

× No keyword cloud information.

13 in total

1. Aberrant Expression of Histamine-independent Pruritogenic Mediators in Keratinocytes may be Involved in the Pathogenesis of Prurigo Nodularis.

Authors: Weilong Zhong; Xia Wu; Wei Zhang; Jie Zhang; Xiaofan Chen; Shihong Chen; Haiyan Huang; Yong Yang; Bo Yu; Xia Dou
Journal: Acta Derm Venereol Date: 2019-05-01 Impact factor: 4.437

2. Non-Histaminergic Itch Mediators Elevated in the Skin of a Porcine Model of Scabies and of Human Scabies Patients.

Authors: Kristen M Sanders; Leigh A Nattkemper; Jordan D Rosen; Hjalte H Andersen; Jeremy Hsiang; Paolo Romanelli; Charlotte Bernigaud; Jacques Guillot; Olivier Chosidow; Gil Yosipovitch
Journal: J Invest Dermatol Date: 2018-11-02 Impact factor: 8.551

3. Increased expression of mRNAs for IL-4, IL-17, IL-22 and IL-31 in skin lesions of subacute and chronic forms of prurigo.

Authors: Kio Park; Tomoko Mori; Motonobu Nakamura; Yoshiki Tokura
Journal: Eur J Dermatol Date: 2011 Jan-Feb Impact factor: 3.328

4. Prurigo nodularis: New treatments on the horizon.

Authors: Gil Yosipovitch
Journal: J Am Acad Dermatol Date: 2020-04 Impact factor: 11.527

5. Pathophysiologic mechanisms of itch in bullous pemphigoid.

Authors: Takashi Hashimoto; Christina Dorothy Kursewicz; Rachel Alison Fayne; Sonali Nanda; Serena Maya Shah; Leigh Nattkemper; Hiroo Yokozeki; Gil Yosipovitch
Journal: J Am Acad Dermatol Date: 2019-07-25 Impact factor: 11.527

6. Periostin promotes chronic allergic inflammation in response to Th2 cytokines.

Authors: Miho Masuoka; Hiroshi Shiraishi; Shoichiro Ohta; Shoichi Suzuki; Kazuhiko Arima; Shigehisa Aoki; Shuji Toda; Naoki Inagaki; Yuichi Kurihara; Sayaka Hayashida; Satoshi Takeuchi; Kenta Koike; Junya Ono; Hirokazu Noshiro; Masutaka Furue; Simon J Conway; Yutaka Narisawa; Kenji Izuhara
Journal: J Clin Invest Date: 2012-06-11 Impact factor: 14.808

7. Pruritus in ordinary scabies: IL-31 from macrophages induced by overexpression of thymic stromal lymphopoietin and periostin.

Authors: Takashi Hashimoto; Takahiro Satoh; Hiroo Yokozeki
Journal: Allergy Date: 2019-06-02 Impact factor: 13.146

8. Periostin contributes to the pathogenesis of atopic dermatitis by inducing TSLP production from keratinocytes.

Authors: Hiroshi Shiraishi; Miho Masuoka; Shoichiro Ohta; Shoichi Suzuki; Kazuhiko Arima; Kazuto Taniguchi; Shigehisa Aoki; Shuji Toda; Tomohiro Yoshimoto; Naoki Inagaki; Simon J Conway; Yutaka Narisawa; Kenji Izuhara
Journal: Allergol Int Date: 2012-08-25 Impact factor: 5.836

9. Mechanisms of Itch in Stasis Dermatitis: Significant Role of IL-31 from Macrophages.

Authors: Takashi Hashimoto; Christina Dorothy Kursewicz; Rachel Alison Fayne; Sonali Nanda; Serena Maya Shah; Leigh Nattkemper; Hiroo Yokozeki; Gil Yosipovitch
Journal: J Invest Dermatol Date: 2019-10-15 Impact factor: 8.551

10. Periostin Activation of Integrin Receptors on Sensory Neurons Induces Allergic Itch.

Authors: Santosh K Mishra; Joshua J Wheeler; Saumitra Pitake; Huiping Ding; Changyu Jiang; Tomoki Fukuyama; Judy S Paps; Patrick Ralph; Jacob Coyne; Michelle Parkington; Jennifer DeBrecht; Lauren C Ehrhardt-Humbert; Glenn P Cruse; Wolfgang Bäumer; Ru-Rong Ji; Mei-Chuan Ko; Thierry Olivry
Journal: Cell Rep Date: 2020-04-07 Impact factor: 9.995

5 in total

Dermal Periostin: A New Player in Itch of Prurigo Nodularis.

1. Aberrant Expression of Histamine-independent Pruritogenic Mediators in Keratinocytes may be Involved in the Pathogenesis of Prurigo Nodularis.

2. Non-Histaminergic Itch Mediators Elevated in the Skin of a Porcine Model of Scabies and of Human Scabies Patients.

3. Increased expression of mRNAs for IL-4, IL-17, IL-22 and IL-31 in skin lesions of subacute and chronic forms of prurigo.

4. Prurigo nodularis: New treatments on the horizon.

5. Pathophysiologic mechanisms of itch in bullous pemphigoid.

6. Periostin promotes chronic allergic inflammation in response to Th2 cytokines.

7. Pruritus in ordinary scabies: IL-31 from macrophages induced by overexpression of thymic stromal lymphopoietin and periostin.

8. Periostin contributes to the pathogenesis of atopic dermatitis by inducing TSLP production from keratinocytes.

9. Mechanisms of Itch in Stasis Dermatitis: Significant Role of IL-31 from Macrophages.

10. Periostin Activation of Integrin Receptors on Sensory Neurons Induces Allergic Itch.

Review 1. Pruritus in Keloid Scars: Mechanisms and Treatments.

Review 2. Immunotargets and Therapy for Prurigo Nodularis.

Review 3. Critical Players and Therapeutic Targets in Chronic Itch.

Review 4. Chronic itch in African Americans: an unmet need.

Review 5. Pruritus as a Distinctive Feature of Type 2 Inflammation.